Center for Infectious Diseases and The Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Chancellor's Building, Edinburgh EH164SB, United Kingdom.
Microbes Infect. 2011 Mar;13(3):216-25. doi: 10.1016/j.micinf.2010.10.016. Epub 2010 Oct 29.
Cardiac vegetations result from bacterium-platelet adherence, activation and aggregation, and are associated with increased morbidity and mortality in infective endocarditis. The GPIIb/IIIa and FcγRIIa platelet receptors play a central role in platelet adhesion, activation and aggregation induced by endocarditis pathogens such as Staphylococcus aureus, but the influence of known polymorphisms of these receptors on the pathogenesis of infective endocarditis is unknown. We determined the GPIIIa platelet antigen Pl(A1/A2) and FcγRIIa H131R genotype of healthy volunteers (n = 160) and patients with infective endocarditis (n = 40), and investigated the influence of these polymorphisms on clinical outcome in infective endocarditis and S. aureus-platelet interactions in vitro. Platelet receptor genotype did not correlate with development of infective endocarditis, vegetation characteristics on echocardiogram or the composite clinical end-point of embolism, heart failure, need for surgery or mortality (P > 0.05 for all), even though patients with the GPIIIa Pl(A1/A1) genotype had increased in vivo platelet activation (P = 0.001). Furthermore, neither GPIIIa Pl(A1/A2) nor FcγRIIa H131R genotype influenced S. aureus-induced platelet adhesion, activation or aggregation in vitro (P > 0.05). Taken together, our data suggest that the GPIIIa and FcγRIIa platelet receptor polymorphisms do not influence S. aureus-platelet interactions in vitro or the clinical course of infective endocarditis.
心瓣膜赘生物是由细菌-血小板黏附、激活和聚集引起的,与感染性心内膜炎的发病率和死亡率增加有关。血小板受体 GPIIb/IIIa 和 FcγRIIa 在金黄色葡萄球菌等感染性心内膜炎病原体引起的血小板黏附、激活和聚集中起核心作用,但这些受体的已知多态性对感染性心内膜炎发病机制的影响尚不清楚。我们确定了健康志愿者(n=160)和感染性心内膜炎患者(n=40)的血小板抗原 GPIIIa Pl(A1/A2)和 FcγRIIa H131R 基因型,并研究了这些多态性对感染性心内膜炎临床结局和金黄色葡萄球菌-血小板相互作用的影响。血小板受体基因型与感染性心内膜炎的发生、超声心动图上的赘生物特征或栓塞、心力衰竭、需要手术或死亡的复合临床终点均无相关性(所有 P 值均>0.05),尽管 GPIIIa Pl(A1/A1)基因型患者体内血小板激活增加(P=0.001)。此外,GPIIIa Pl(A1/A2)和 FcγRIIa H131R 基因型均不影响金黄色葡萄球菌诱导的血小板黏附、激活或聚集(P>0.05)。总之,我们的数据表明,GPIIIa 和 FcγRIIa 血小板受体多态性不影响体外金黄色葡萄球菌-血小板相互作用或感染性心内膜炎的临床病程。
Arterioscler Thromb Vasc Biol. 2010-11-11
J Heart Valve Dis. 2013-1
Circulation. 2004-7-13
Cochrane Database Syst Rev. 2020-5-14
Nat Rev Microbiol. 2014-6
Biochemistry. 2007-12-18
Circulation. 2006-10-10
Crit Rev Oncol Hematol. 2006-11
Nat Rev Microbiol. 2006-6
Curr Probl Cardiol. 2006-4